Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Salt Lake City, Utah 84107


Purpose:

Study to Evaluate Home Vision Testing in Patients Receiving Ranibizumab


Criteria:

Inclusion Criteria: - Diabetic Macular Edema (DME) or active neovascular age-related Macular Degeneration (nAMD) in at least one eye - Current treatment with intravitreal Lucentis® therapy, with evaluations planned every 4 to 8 weeks - Best corrected visual acuity (Snellen assessed by glasses and/or contact lens) of 20/100 or better in the study eye, with potential for vision recovery with standard-of-care treatment - Age >= 18 years - Access to an approved mobile device with a data plan or WiFi internet access Exclusion Criteria: - Any other eye condition causing eye disease that limits vision and cannot be corrected, other than Diabetic Macular Edema (DME) or neovascular age-related Macular Degeneration (nAMD). - Dementia or other neurologic or psychological limitation that would prevent the patient from performing regular self-testing of visual function.


NCT ID:

NCT02420132


Primary Contact:

Study Director
Clinical Trials
Hoffmann-La Roche


Backup Contact:

N/A


Location Contact:

Salt Lake City, Utah 84107
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 24, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.